Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Intake of Novel Red Clover Supplementation for 12 Weeks Improves Bone Status in Healthy Menopausal Women.

Thorup AC, Lambert MN, Kahr HS, Bjerre M, Jeppesen PB.

Evid Based Complement Alternat Med. 2015;2015:689138. doi: 10.1155/2015/689138. Epub 2015 Jul 21.

2.

Evaluation of bone, nutrition, and physical function in Shorinji Kempo athletes.

Sumida S, Iwamoto J, Kamide N, Otani T.

Open Access J Sports Med. 2012 Sep 10;3:107-14. doi: 10.2147/OAJSM.S34010. eCollection 2012.

3.

Effect of risedronate on speed of sound in postmenopausal women with osteoporosis.

Iwamoto J, Takada T, Sato Y, Matsumoto H.

World J Orthop. 2013 Oct 18;4(4):316-22. doi: 10.5312/wjo.v4.i4.316. eCollection 2013.

4.

Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults.

Garfield LD, Müller DJ, Kennedy JL, Mulsant BH, Reynolds CF 3rd, Teitelbaum SL, Civitelli R, Dixon D, Todorov AA, Lenze EJ.

World J Biol Psychiatry. 2014 Jul;15(5):404-10. doi: 10.3109/15622975.2013.832380. Epub 2013 Sep 30.

5.

Effects of dietary isoflavones from Puerariae radix on lipid and bone metabolism in ovariectomized rats.

Lim DW, Kim JG, Kim YT.

Nutrients. 2013 Jul 17;5(7):2734-46. doi: 10.3390/nu5072734.

6.

Eleven years of experience with bisphosphonate plus alfacalcidol treatment in a man with osteogenesis imperfecta type I.

Iwamoto J, Sato Y, Uzawa M, Matsumoto H.

Ther Clin Risk Manag. 2013;9:1-7. doi: 10.2147/TCRM.S38404. Epub 2012 Dec 28.

7.

Bone turnover markers do not predict stress fracture in elite combat recruits.

Yanovich R, Evans RK, Friedman E, Moran DS.

Clin Orthop Relat Res. 2013 Apr;471(4):1365-72. doi: 10.1007/s11999-012-2727-3. Epub 2012 Dec 13.

8.
9.

Serum leptin concentration positively correlates with body weight and total fat mass in postmenopausal Japanese women with osteoarthritis of the knee.

Iwamoto J, Takeda T, Sato Y, Matsumoto H.

Arthritis. 2011;2011:580632. doi: 10.1155/2011/580632. Epub 2011 Jan 24.

10.

Anamnestic risk factor questionnaire as reliable diagnostic instrument for osteoporosis (reduced bone morphogenic density).

Kolios L, Takur C, Moghaddam A, Hitzler M, Schmidt-Gayk H, Suda AJ, Höner B, Grützner PA, Wölfl C.

BMC Musculoskelet Disord. 2011 Aug 17;12:187. doi: 10.1186/1471-2474-12-187.

11.

Seven years' experience with etidronate in a woman with anorexia nervosa and vertebral fractures.

Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H.

Ther Clin Risk Manag. 2011;7:275-81. doi: 10.2147/TCRM.S21357. Epub 2011 Jul 5.

12.

Comparison in bone turnover markers during early healing of femoral neck fracture and trochanteric fracture in elderly patients.

Ikegami S, Kamimura M, Nakagawa H, Takahara K, Hashidate H, Uchiyama S, Kato H.

Orthop Rev (Pavia). 2009 Oct 10;1(2):e21. doi: 10.4081/or.2009.e21.

13.

Three-year experience with combined treatment with alendronate and alfacalcidol in Japanese patients with severe bone loss and osteoporotic fracture.

Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H.

Ther Clin Risk Manag. 2011;7:257-64. doi: 10.2147/TCRM.S22167. Epub 2011 Jun 29.

14.

A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene and bone mineral density in Japanese male workers.

Funakoshi Y, Omori H, Yada H, Katoh T.

Environ Health Prev Med. 2011 Mar;16(2):106-12. doi: 10.1007/s12199-010-0172-z. Epub 2010 Aug 11.

15.

Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures.

Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H.

Ther Clin Risk Manag. 2010 Dec 6;6:593-600. doi: 10.2147/TCRM.S15812.

16.

Seven years' experience with alendronate in postmenopausal Japanese women with osteoporosis.

Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H.

Ther Clin Risk Manag. 2010 Apr 26;6:201-6.

17.

Subchondral insufficiency fracture of the femoral head may be associated with hip dysplasia: a pilot study.

Ishihara K, Miyanishi K, Ihara H, Jingushi S, Torisu T.

Clin Orthop Relat Res. 2010 May;468(5):1331-5. doi: 10.1007/s11999-009-1213-z. Epub 2010 Jan 8.

18.
19.

Comparison of the effects of alendronate and alfacalcidol on hip bone mineral density and bone turnover in Japanese men having osteoporosis or osteopenia with clinical risk factors for fractures.

Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H.

Yonsei Med J. 2009 Aug 31;50(4):474-81. doi: 10.3349/ymj.2009.50.4.474. Epub 2009 Aug 19.

20.

Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis.

Iwamoto J, Uzawa M, Sato Y, Takeda T, Matsumoto H.

Ther Clin Risk Manag. 2009 Jun;5(3):499-505. Epub 2009 Jul 12.

Items per page

Supplemental Content

Write to the Help Desk